We refer to our announcement dated 26 January 2021.
The Board of Directors of Pharmaniaga Berhad (“the Company”) wishes to announce that Pharmaniaga Lifescience Sdn Bhd, a wholly-owned subsidiary of the Company has on 22 March 2021 entered into an Agreement with Government of Malaysia, represented by Ministry of Health for the supply and distribution of Covid-19 vaccine, developed by SINOVAC Life Sciences Co. Ltd.
Please refer to the attachment for details of the announcement.
This announcement is dated 22 March 2021.